Mizuno Y - Search Results

1

Early addition of selegiline to L-Dopa treatment is beneficial for patients with Parkinson disease.

Mizuno Y, Kondo T, Kuno S, Nomoto M, Yanagisawa N. Mizuno Y, et al. Clin Neuropharmacol. 2010 Jan-Feb;33(1):1-4. doi: 10.1097/WNF.0b013e3181bbf45c. Clin Neuropharmacol. 2010. PMID: 19935410

2

[Long-term treatment of Parkinson's disease patients with selegiline hydrochloride (FPF 1100): outcome of 5-year treatment].

Kondo T, Takubo H, Yokochi F, Okuma Y, Mizuno Y. Kondo T, et al. Among authors: mizuno y. No To Shinkei. 2002 Dec;54(12):1041-8. No To Shinkei. 2002. PMID: 12599519 Japanese.

3

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

Mizuno Y, Yanagisawa N, Kuno S, Yamamoto M, Hasegawa K, Origasa H, Kowa H; Japanese Pramipexole Study Group. Mizuno Y, et al. Mov Disord. 2003 Oct;18(10):1149-56. doi: 10.1002/mds.10508. Mov Disord. 2003. PMID: 14534919 Clinical Trial.

4

Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients.

Mizuno Y, Kanazawa I, Kuno S, Yanagisawa N, Yamamoto M, Kondo T. Mizuno Y, et al. Mov Disord. 2007 Jan;22(1):75-80. doi: 10.1002/mds.21218. Mov Disord. 2007. PMID: 17094103 Clinical Trial.

5

Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.

Mizuno Y, Abe T, Hasegawa K, Kuno S, Kondo T, Yamamoto M, Nakashima M, Kanazawa I; STRONG Study Group. Mizuno Y, et al. Mov Disord. 2007 Oct 15;22(13):1860-5. doi: 10.1002/mds.21313. Mov Disord. 2007. PMID: 17618525 Clinical Trial.

6

Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial.

Mizuno Y, Yamamoto M, Kuno S, Hasegawa K, Hattori N, Kagimura T, Sarashina A, Rascol O, Schapira AH, Barone P, Hauser RA, Poewe W; Pramipexole ER Study Group. Mizuno Y, et al. Clin Neuropharmacol. 2012 Jul-Aug;35(4):174-81. doi: 10.1097/WNF.0b013e31825f77b9. Clin Neuropharmacol. 2012. PMID: 22801294 Clinical Trial.

7

Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study.

Mizuno Y, Nomoto M, Hasegawa K, Hattori N, Kondo T, Murata M, Takeuchi M, Takahashi M, Tomida T; Rotigotine Trial Group. Mizuno Y, et al. Parkinsonism Relat Disord. 2014 Dec;20(12):1388-93. doi: 10.1016/j.parkreldis.2014.10.005. Epub 2014 Oct 12. Parkinsonism Relat Disord. 2014. PMID: 25455692 Free article. Clinical Trial.

8

A long-term study of istradefylline safety and efficacy in patients with Parkinson disease.

Kondo T, Mizuno Y; Japanese Istradefylline Study Group. Kondo T, et al. Among authors: mizuno y. Clin Neuropharmacol. 2015 Mar-Apr;38(2):41-6. doi: 10.1097/WNF.0000000000000073. Clin Neuropharmacol. 2015. PMID: 25768849 Clinical Trial.

9

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N. Mizuno Y, et al. Clin Neuropharmacol. 2017 Sep/Oct;40(5):201-207. doi: 10.1097/WNF.0000000000000239. Clin Neuropharmacol. 2017. PMID: 28857772 Free PMC article. Clinical Trial.

10

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N. Mizuno Y, et al. Clin Neuropharmacol. 2019 Jul/Aug;42(4):123-130. doi: 10.1097/WNF.0000000000000343. Clin Neuropharmacol. 2019. PMID: 31045589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,587 results

Search Page

Filters